Search results for "kings college london"

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Imperial College London scientists have created artificial cells that mimic biological cells by responding to a chemical change in their surroundings

1 in 3 Phase II trials were terminated in 2024

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London

CUSABIO is a National High-Tech Enterprise with research, production and sales in one. After 17 years of effort, CUSABIO has become a good partner to researchers through worldwide. Dedicated to providing 67,000+ validated antibodies, 13,000+ recombinant proteins, 660+ cytokines and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc. All kinds of CUSABIO products can meet customers' different demands in various scientific research fields.

Engage with leading minds and the latest technology solutions to tackle today’s analytical challenges

ECM675 uses purified chicken type I collagen in 6mM acetate buffer pH 7.0. The product is 99.9% pure native atelomeric avian collagen. Approximately 85% type I and 15% type III collagen protein. The material has been specially prepared to maintain its native state as much as possible. The telomeric ends of the collagen I have been enzymatically removed. Since most of the species identity is found within the telomeric ends, our…

Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture  

The supercomputer is designed to solve some of the world’s most pressing medical challenges

Agreement with Illumina brings industry-leading sequencing platforms together with Devyser’s validated genetic testing solutions